Chuanfen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chuanfen Liu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Hong Zhao
Department of Cardiology
2 shared publications - Jian Liu
Department of Cardiology, Peking University People’s Hospital, Beijing 100044, China
2 shared publications Chang Hou
Department of Cardiology, Peking University People's Hospital
1 shared publication- Chang Hou
Department of Cardiology
1 shared publication - Chongyou Lee
Department of Cardiology (L.-N., J.-X.S., C.L.), Center for Cardiovascular Translational Research, Beijing Key Laboratory of Innovative Drug and Device Translation in Endocrine and Metabolic Diseases, Peking University People’s Hospital, China
1 shared publication - Chunying Zhang
Department of Cardiology, Peking University People’s Hospital, Beijing 100044, China
1 shared publication
Latest Publications
- Open Access
- 11 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (18) , e040649
VEGFC/VEGFR3 Signaling‐Dependent Lymphatic Remodeling Modulates Cardiac Response to Pressure Overload
Background: Cardiac lymphangiogenesis has been proposed as a potential therapeutic target to prevent the development of heart failure. However, the efficiency of systemically delivered VEGFC ( vascular endothelial growth factor C) protein in inducing cardiac lymphangiogenesis has shown inconsistency across different studies. Moreover, the mechanisms underlying lymphatic remodeling during heart failure remain poorly understood. Methods: To determine the role of lymphatic remodeling in heart failure, we used adeno‐associated virus–mediated gene therapy to either inhibit VEGFR3 ( vascular endothelial growth factor receptor 3) expression or enhance VEGFC expression in mice subjected to transverse aortic constriction. In vitro studies were further conducted to investigate the role of Yes‐associated protein in VEGFC/VEGFR3 signaling in lymphatic endothelial cells. Results: Our study shows that transverse aortic constriction induces dynamic lymphatic remodeling, characterized by an early adaptive cardiac lymphangiogenic response and enhanced peripheral lymphatic transport function. Adeno‐associated virus‐sh‐VEGFR3 treatment inhibited this early adaptive lymphangiogenesis, exacerbating cardiac inflammation and adverse remodeling. Conversely, adeno‐associated virus–VEGFC therapy appeared to be cardioprotective by promoting adaptive lymphangiogenesis and facilitating the resolution of cardiac inflammation. Moreover, adeno‐associated virus–VEGFC treatment improved peripheral lymphatic drainage function, potentially alleviating peripheral congestion in heart failure. Further in vivo and in vitro analyses revealed that Yes‐associated protein dephosphorylation is essential for VEGFC/VEGFR3 signaling‐dependent lymphangiogenesis and for upregulation of lymphatic chemokines and scavenger receptors. Conclusions: These findings highlight that targeting cardiac lymphangiogenesis via VEGFC/VEGFR3 signaling through genetic approaches represents a promising therapeutic strategy for heart failure. Moreover, VEGFC administration may offer a novel, noninvasive decongestive approach by modulating the lymphatic system in heart failure management.
- 11 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (18) , e040649
Open AccessVEGFC/VEGFR3 Signaling‐Dependent Lymphatic Remodeling Modulates Cardiac Response to Pressure Overload
Background: Cardiac lymphangiogenesis has been proposed as a potential therapeutic target to prevent the development of heart failure. However, the efficiency of systemically delivered VEGFC ( vascular endothelial growth factor C) protein in inducing cardiac lymphangiogenesis has shown inconsistency across different studies. Moreover, the mechanisms underlying lymphatic remodeling during heart failure remain poorly understood. Methods: To determine the role of lymphatic remodeling in heart failure, we used adeno‐associated virus–mediated gene therapy to either inhibit VEGFR3 ( vascular endothelial growth factor receptor 3) expression or enhance VEGFC expression in mice subjected to transverse aortic constriction. In vitro studies were further conducted to investigate the role of Yes‐associated protein in VEGFC/VEGFR3 signaling in lymphatic endothelial cells. Results: Our study shows that transverse aortic constriction induces dynamic lymphatic remodeling, characterized by an early adaptive cardiac lymphangiogenic response and enhanced peripheral lymphatic transport function. Adeno‐associated virus‐sh‐VEGFR3 treatment inhibited this early adaptive lymphangiogenesis, exacerbating cardiac inflammation and adverse remodeling. Conversely, adeno‐associated virus–VEGFC therapy appeared to be cardioprotective by promoting adaptive lymphangiogenesis and facilitating the resolution of cardiac inflammation. Moreover, adeno‐associated virus–VEGFC treatment improved peripheral lymphatic drainage function, potentially alleviating peripheral congestion in heart failure. Further in vivo and in vitro analyses revealed that Yes‐associated protein dephosphorylation is essential for VEGFC/VEGFR3 signaling‐dependent lymphangiogenesis and for upregulation of lymphatic chemokines and scavenger receptors. Conclusions: These findings highlight that targeting cardiac lymphangiogenesis via VEGFC/VEGFR3 signaling through genetic approaches represents a promising therapeutic strategy for heart failure. Moreover, VEGFC administration may offer a novel, noninvasive decongestive approach by modulating the lymphatic system in heart failure management.
- Open Access
- 14 July 2022
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2022, 1-8
The Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Left Ventricular Performance Recovery in Patients with ST-Segment Elevation Myocardial Infarction
Objectives. The present study is designed to investigate the impact of coronary angiography-derived index of microcirculatory resistance (caIMR) on left ventricular performance recovery. Background. IMR has been established as a gold standard for coronary microvascular assessment and a predictor of left ventricular recovery after ST-segment elevation myocardial infarction (STEMI). CaIMR is a novel and accurate alternative of IMR. Methods. The present study retrospectively included 80 patients with STEMI who underwent primary percutaneous coronary intervention (PCI). We offline performed the post-PCI caIMR analysis of the culprit vessel. Echocardiography was performed within the first 24 hours and at 3 months after the index procedure. Left ventricular recovery was defined as the change in left ventricular ejection fraction (LVEF) more than zero. Results. The mean age of the patients was 58.0 years with 80.0 male. The average post-PCI caIMR was 43.2. Overall left ventricular recovery was seen in 41 patients. Post-PCI caIMR (OR: 0.948, 95 CI: 0.9160.981, p=0.002), left anterior descending as the culprit vessel (OR: 3.605, 95 CI: 1.2310.567, p=0.019), and male (OR: 0.254, 95 CI: 0.0660.979, p=0.047) were independent predictors of left ventricular recovery at 3 months follow-up. A predictive model was established with the best cutoff value for the prediction of left ventricular recovery 2.33 (sensitivity 0.610, specificity 0.897, and area under the curve 0.765). In patients with a predictive model score less than 2.33, the LVEF increased significantly at 3 months. Conclusions. The post-PCI caIMR can accurately predict left ventricular functional recovery at 3 months follow-up in patients with STEMI treated by primary PCI, supporting its use in clinical practice.
- 14 July 2022
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2022, 1-8
Open AccessThe Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Left Ventricular Performance Recovery in Patients with ST-Segment Elevation Myocardial Infarction
Objectives. The present study is designed to investigate the impact of coronary angiography-derived index of microcirculatory resistance (caIMR) on left ventricular performance recovery. Background. IMR has been established as a gold standard for coronary microvascular assessment and a predictor of left ventricular recovery after ST-segment elevation myocardial infarction (STEMI). CaIMR is a novel and accurate alternative of IMR. Methods. The present study retrospectively included 80 patients with STEMI who underwent primary percutaneous coronary intervention (PCI). We offline performed the post-PCI caIMR analysis of the culprit vessel. Echocardiography was performed within the first 24 hours and at 3 months after the index procedure. Left ventricular recovery was defined as the change in left ventricular ejection fraction (LVEF) more than zero. Results. The mean age of the patients was 58.0 years with 80.0 male. The average post-PCI caIMR was 43.2. Overall left ventricular recovery was seen in 41 patients. Post-PCI caIMR (OR: 0.948, 95 CI: 0.9160.981, p=0.002), left anterior descending as the culprit vessel (OR: 3.605, 95 CI: 1.2310.567, p=0.019), and male (OR: 0.254, 95 CI: 0.0660.979, p=0.047) were independent predictors of left ventricular recovery at 3 months follow-up. A predictive model was established with the best cutoff value for the prediction of left ventricular recovery 2.33 (sensitivity 0.610, specificity 0.897, and area under the curve 0.765). In patients with a predictive model score less than 2.33, the LVEF increased significantly at 3 months. Conclusions. The post-PCI caIMR can accurately predict left ventricular functional recovery at 3 months follow-up in patients with STEMI treated by primary PCI, supporting its use in clinical practice.
- Open Access
- 15 February 2022
- Published by Springer Nature in Research Square
A Novel Optical Coherence Tomography-Based Calcium Scoring System Can Predict Stent Expansion of Moderate and Severe Calcified Lesions
Background: Coronary calcified lesions have a serious effect on stent expansion. Researchers have developed a calcium scoring system based on optical coherence tomography (OCT) to identify relatively mild calcified lesions that would benefit from plaque modification. The present study is designed to establish a novel OCT-based scoring system to predict stent expansion of moderate and severe calcified lesions.Methods: The present study retrospectively included 33 patients (34 calcified lesions observed on coronary angiography) who underwent OCT-guided percutaneous coronary intervention (PCI) at Peking University People's Hospital from January 2016 to July 2021. We off-line reviewed and analysed the images of coronary angiography and OCT. We then developed a calcium scoring system and found the optimal threshold for the prediction of stent underexpansion in patients with moderate and severe calcified lesions.Results: The average age of the patients was 67 years. Overall final post-PCI stent expansion was 70.74%, and poor stent expansion (i.e., stent expansion < 80%) was seen in 23 lesions. Approximately 89% of the lesions manifested as angiographically visible moderate and severe coronary calcification. The average maximum calcium arc, length and thickness assessed by OCT were 230°, 25.10 mm and 1.18 mm, respectively. Multivariate logistic regression model showed that age (OR: 1.173, 95% CI: 1.036~1.438, p = 0.042) and maximum calcium arc (OR: 1.023, 95% CI: 1.008~1.050, p = 0.021) were independent predictors of stent underexpansion. A novel calcium scoring system was established as: 0.16 × age + 0.03 × maximum calcium arc, and the best cut-off of the system for the prediction of stent underexpansion was 16.87 (sensitivity 0.870, specificity 0.909, area under the curve [AUC] 0.925, 95% CI: 0.836~1.014, p < 0.001). Receiver operating characteristics curve analysis showed that the novel scoring system had larger AUC than the previous scoring system (0.925 vs 0.706, p = 0.002).Conclusions: The calcium scoring system based on age and maximum calcium arc obtained from OCT may more accurately predict the risk of poor stent expansion in patients with moderate and severe calcified lesions.
- 15 February 2022
- Published by Springer Nature in Research Square
Open AccessA Novel Optical Coherence Tomography-Based Calcium Scoring System Can Predict Stent Expansion of Moderate and Severe Calcified Lesions
Background: Coronary calcified lesions have a serious effect on stent expansion. Researchers have developed a calcium scoring system based on optical coherence tomography (OCT) to identify relatively mild calcified lesions that would benefit from plaque modification. The present study is designed to establish a novel OCT-based scoring system to predict stent expansion of moderate and severe calcified lesions.Methods: The present study retrospectively included 33 patients (34 calcified lesions observed on coronary angiography) who underwent OCT-guided percutaneous coronary intervention (PCI) at Peking University People's Hospital from January 2016 to July 2021. We off-line reviewed and analysed the images of coronary angiography and OCT. We then developed a calcium scoring system and found the optimal threshold for the prediction of stent underexpansion in patients with moderate and severe calcified lesions.Results: The average age of the patients was 67 years. Overall final post-PCI stent expansion was 70.74%, and poor stent expansion (i.e., stent expansion < 80%) was seen in 23 lesions. Approximately 89% of the lesions manifested as angiographically visible moderate and severe coronary calcification. The average maximum calcium arc, length and thickness assessed by OCT were 230°, 25.10 mm and 1.18 mm, respectively. Multivariate logistic regression model showed that age (OR: 1.173, 95% CI: 1.036~1.438, p = 0.042) and maximum calcium arc (OR: 1.023, 95% CI: 1.008~1.050, p = 0.021) were independent predictors of stent underexpansion. A novel calcium scoring system was established as: 0.16 × age + 0.03 × maximum calcium arc, and the best cut-off of the system for the prediction of stent underexpansion was 16.87 (sensitivity 0.870, specificity 0.909, area under the curve [AUC] 0.925, 95% CI: 0.836~1.014, p < 0.001). Receiver operating characteristics curve analysis showed that the novel scoring system had larger AUC than the previous scoring system (0.925 vs 0.706, p = 0.002).Conclusions: The calcium scoring system based on age and maximum calcium arc obtained from OCT may more accurately predict the risk of poor stent expansion in patients with moderate and severe calcified lesions.
- 8 March 2021
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (4) , 1-18
Cardiovascular Magnetic Resonance Imaging and Heart Failure
Purpose of Review The purpose of this review is to summarize the application of cardiac magnetic resonance (CMR) in the diagnostic and prognostic evaluation of patients with heart failure (HF). Recent Findings CMR is an important non-invasive imaging modality in the assessment of ventricular volumes and function and in the analysis of myocardial tissue characteristics. The information derived from CMR provides a comprehensive evaluation of HF. Its unique ability of tissue characterization not only helps to reveal the underlying etiologies of HF but also offers incremental prognostic information. Summary CMR is a useful non-invasive tool for the diagnosis and assessment of prognosis in patients suffering from heart failure.
- 8 March 2021
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (4) , 1-18
Cardiovascular Magnetic Resonance Imaging and Heart Failure
Purpose of Review The purpose of this review is to summarize the application of cardiac magnetic resonance (CMR) in the diagnostic and prognostic evaluation of patients with heart failure (HF). Recent Findings CMR is an important non-invasive imaging modality in the assessment of ventricular volumes and function and in the analysis of myocardial tissue characteristics. The information derived from CMR provides a comprehensive evaluation of HF. Its unique ability of tissue characterization not only helps to reveal the underlying etiologies of HF but also offers incremental prognostic information. Summary CMR is a useful non-invasive tool for the diagnosis and assessment of prognosis in patients suffering from heart failure.